AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AMWL • US03044L2043

4.25 USD
-0.15 (-3.41%)
Last: Feb 5, 2026, 08:09 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMWL. AMWL was compared to 35 industry peers in the Health Care Technology industry. While AMWL has a great health rating, there are worries on its profitability. AMWL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • AMWL had negative earnings in the past year.
  • AMWL had a negative operating cash flow in the past year.
  • AMWL had negative earnings in each of the past 5 years.
  • In the past 5 years AMWL always reported negative operating cash flow.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • AMWL has a worse Return On Assets (-31.56%) than 62.86% of its industry peers.
  • AMWL has a Return On Equity (-44.50%) which is in line with its industry peers.
Industry RankSector Rank
ROA -31.56%
ROE -44.5%
ROIC N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

  • AMWL has a worse Gross Margin (52.93%) than 65.71% of its industry peers.
  • AMWL's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AMWL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

7

2. Health

2.1 Basic Checks

  • AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AMWL has been reduced compared to 1 year ago.
  • AMWL has less shares outstanding than it did 5 years ago.
  • AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • Based on the Altman-Z score of -7.19, we must say that AMWL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -7.19, AMWL is doing worse than 82.86% of the companies in the same industry.
  • There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.19
ROIC/WACCN/A
WACC9.54%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • AMWL has a Current Ratio of 3.14. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AMWL (3.14) is better than 68.57% of its industry peers.
  • A Quick Ratio of 3.11 indicates that AMWL has no problem at all paying its short term obligations.
  • The Quick ratio of AMWL (3.11) is better than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.11
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.07% over the past year.
  • AMWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.33%.
  • AMWL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.30% yearly.
EPS 1Y (TTM)46.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.31%
Revenue 1Y (TTM)4.33%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%-7.8%

3.2 Future

  • Based on estimates for the next years, AMWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.97% on average per year.
  • The Revenue is expected to grow by 0.88% on average over the next years.
EPS Next Y55.07%
EPS Next 2Y28.88%
EPS Next 3Y20.77%
EPS Next 5Y12.97%
Revenue Next Year-1.28%
Revenue Next 2Y-1.91%
Revenue Next 3Y0.66%
Revenue Next 5Y0.88%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AMWL's earnings are expected to grow with 20.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.88%
EPS Next 3Y20.77%

0

5. Dividend

5.1 Amount

  • AMWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (2/5/2026, 8:09:18 PM)

4.25

-0.15 (-3.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04
Earnings (Next)02-10
Inst Owners40.07%
Inst Owner Change0%
Ins Owners4.08%
Ins Owner Change0.19%
Market Cap69.57M
Revenue(TTM)265.02M
Net Income(TTM)-113.43M
Analysts70.67
Price Target8.33 (96%)
Short Float %1.08%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.58%
Min EPS beat(2)-9.03%
Max EPS beat(2)30.19%
EPS beat(4)3
Avg EPS beat(4)14.89%
Min EPS beat(4)-9.03%
Max EPS beat(4)31.2%
EPS beat(8)6
Avg EPS beat(8)10.08%
EPS beat(12)7
Avg EPS beat(12)-7.18%
EPS beat(16)10
Avg EPS beat(16)-3.2%
Revenue beat(2)2
Avg Revenue beat(2)4.89%
Min Revenue beat(2)1.14%
Max Revenue beat(2)8.64%
Revenue beat(4)4
Avg Revenue beat(4)5.82%
Min Revenue beat(4)1.14%
Max Revenue beat(4)8.93%
Revenue beat(8)4
Avg Revenue beat(8)1.61%
Revenue beat(12)4
Avg Revenue beat(12)-0.13%
Revenue beat(16)5
Avg Revenue beat(16)-0.19%
PT rev (1m)0%
PT rev (3m)-17.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.66%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-7.89
EYN/A
EPS(NY)-4.75
Fwd EYN/A
FCF(TTM)-3.94
FCFYN/A
OCF(TTM)-3.79
OCFYN/A
SpS16.19
BVpS15.57
TBVpS11.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.56%
ROE -44.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.93%
FCFM N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.2%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 3.11
Altman-Z -7.19
F-Score6
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)44.83%
Cap/Depr(5y)34.13%
Cap/Sales(3y)5.21%
Cap/Sales(5y)3.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.31%
EPS Next Y55.07%
EPS Next 2Y28.88%
EPS Next 3Y20.77%
EPS Next 5Y12.97%
Revenue 1Y (TTM)4.33%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%-7.8%
Revenue Next Year-1.28%
Revenue Next 2Y-1.91%
Revenue Next 3Y0.66%
Revenue Next 5Y0.88%
EBIT growth 1Y52.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.78%
EBIT Next 3Y25.56%
EBIT Next 5Y15.16%
FCF growth 1Y61.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.53%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN WELL CORP-CLASS A / AMWL FAQ

Can you provide the ChartMill fundamental rating for AMERICAN WELL CORP-CLASS A?

ChartMill assigns a fundamental rating of 3 / 10 to AMWL.


Can you provide the valuation status for AMERICAN WELL CORP-CLASS A?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN WELL CORP-CLASS A (AMWL). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN WELL CORP-CLASS A?

AMERICAN WELL CORP-CLASS A (AMWL) has a profitability rating of 0 / 10.